Rab Pharma

GHK-Cu is a natural peptide in human blood plasma, urine, and saliva. Research in animals reveals that GHK-Cu can improve wound healing, immune function, and skin health by stimulating collagen, fibroblasts and promoting blood vessel growth. There has been evidence that has shown that it acts as a feedback signal that is generated after tissue injury. It also suppresses free-radical damage and thus is a potent antioxidant.

Peptides will arrive in a lyophilized (powder) form for maximum stability
Add to Cart
Buy 3 for $67.50 each and save 4%
Buy 5 for $65.00 each and save 8%
GHK-Cu Peptide Structure
GHK-Cu Research
Referenced Citations
Certificate of Analysis (COA)
High Performance Liquid Chromatography (HPLC)
Mass Spectrometry (MS)
GHK-Cu
GHK-Cu is a naturally occurring peptide first isolated from human blood plasma. It has since been identified in urine and saliva as well. Research into GHK-Cu has found the short peptide to have substantial benefits in wound healing and immune function. It has anti-aging properties and has been found to suppress free-radical damage, increase protein synthesis, fight bacteria, and increase the

Identification. AOD9604 is a synthetic analogue of the lipolytic domain of human growth hormone, being investigated for the treatment of obesity

Trimix is an injectable medication comprised of papaverine, phentolamine, and alprostadil used as a treatment for erectile dysfunction (ED). Trimix injections can trigger an erection within 5 minutes and result in longer and firmer erections that last through climax. Because Trimix dosages are tailored based on how each patient responds to treatment, it must be prescribed by a healthcare provider.

Erectile dysfunction (ED), a sexual health condition characterized by the inability to achieve or maintain an erection, affects an estimated 15-30 million men in the U.S., with over 600,000 new cases arising each year.[1] While ED can occur in younger men, it becomes more prevalent after age 40. Additionally, large multinational studies have estimated the prevalence of ED in young men to be as high as 30%. It’s predicted that by 2025, 322 million men worldwide will have ED.

BiMix is a prescription treatment for impotence, also known as erectile dysfunction (ED), a condition impacting over 18 million men in the United States. For many patients struggling with erectile dysfunction who have tried “everything else” to produce and maintain an erection, this medication offers new hope.

Administered as a penile self-injection containing papavarine and phentolamine, BiMix is most often prescribed when conventional therapies, such as PDE5 inhibitors, fail.

Retatrutide is most notably being developed for weight loss. In clinical trials, it has demonstrated the potential to help individuals lose over 20% of their body weight. This is a significant breakthrough, particularly for people who have not had success with traditional weight loss methods or other weight loss medications. By targeting multiple metabolic pathways, Retatrutide offers a more comprehensive solution to managing obesity.

AOD-9604 is a peptide fragment derived from human growth hormone (HGH), specifically the modified C-terminal region (176–191). It has been primarily studied for its potential fat-burning and metabolic benefits.
Common Research Uses of AOD-9604:
Fat Loss and Obesity Treatment:
AOD-9604 is designed to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat formation).
It mimics the fat-reducing effects of growth hormone without affecting blood sugar or growth.
Metabolic Enhancement:
It may increase basal metabolic rate (BMR), which can help burn more calories at rest.
Cartilage and Joint Support (Investigational):
Some studies suggest it may aid cartilage repair or reduce joint inflammation, though this is not its primary purpose.
Potential Wound Healing Effects (Exploratory):
Early-stage research hints at regenerative or healing properties, but more evidence is needed.

Tirzepatide is a novel medication approved by the US Food and Drug Administration (FDA) for treating type 2 diabetes mellitus (T2DM). This medication also demonstrates efficacy in weight loss, leading to its off-label use for obesity treatment. Tirzepatide is a dual agonist for the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. The drug leads to significantly improved glycemic control and weight reduction in patients with T2DM, maximizing benefits similar to GLP-1 medications such as semaglutide.

Tirzepatide is currently utilized as a second-line diabetes medication akin to GLP-1 drugs, such as semaglutide, and is administered once weekly via subcutaneous injection with incremental dosage adjustments. Tirzepatide is not approved for the treatment of type 1 diabetes mellitus (T1DM) and has not undergone studies in patients with pancreatitis. The most commonly reported adverse effects of the drug are gastrointestinal, including nausea, vomiting, and diarrhea. This activity provides an overview of the indications, mechanism of action, adverse effects, contraindications, and important considerations for using tirzepatide. This activity also aids clinicians in gaining proficiency in administering tirzepatide and managing T2DM in patients, thereby enhancing overall outcomes in patient care and safety.

Objectives:

Identify appropriate candidates for tirzepatide therapy based on their clinical profile and treatment goals.

Assess patient response to tirzepatide therapy by regularly monitoring glycemic control and weight changes.

Select optimal combination therapies or alternative treatment options for patients with complex medical histories or treatment-resistant diabetes.

Collaborate with interdisciplinary healthcare teams to coordinate care transitions and follow-up appointments to facilitate continuity of tirzepatide therapy and monitor long-term outcomes.

BPC-157 may support the healing of various tissues such as tendons, joints, nerves, the intestinal tract, the stomach, and skin, based on studies in rodents and cultured cells. However, more research is needed to determine its potential benefits in humans.

Tirzepatide is an antidiabetic medication used to treat type 2 diabetes and for weight loss. Tirzepatide is administered via subcutaneous injections (under the skin). In the United States, it is sold under the brand name Mounjaro for diabetes treatment and Zepbound for weight loss and treatment of obstructive sleep apnea.

Bacteriostatic Water (bacteriostatic water for injection) is sterile water containing 0.9% benzyl alcohol that is used to dilute or dissolve medications; the container can be reentered multiple times (usually by a sterile needle) and the benzyl alcohol suppresses or stops the growth of most potentially contaminating ...

NAD+ is a coenzyme essential for energy production, cellular health, and healthy aging. A 100mg dose, often found in supplements like Life Extension NAD+ Cell Regenerator, can help support and maintain healthy NAD+ levels in the body, potentially promoting energy, cellular vitality, and combating age-related decline

Melanotan 2 (MT2) is a synthetic peptide originally developed to stimulate melanin production (the pigment responsible for skin color) and mimic the effects of alpha-melanocyte-stimulating hormone (α-MSH). It is not approved for human use by regulatory agencies like the FDA and is typically labeled "for research purposes only." However, it has been studied and used off-label for various effects.

Commonly Reported or Investigated Uses of Melanotan 2:

Skin Tanning

Stimulates melanin production, leading to darker skin pigmentation without extensive sun exposure.

Erectile Dysfunction

Some studies and anecdotal reports suggest it may enhance libido and sexual function in men, possibly due to its interaction with the central nervous system.

Appetite Suppression

Some users report reduced appetite, although this is not a primary intended effect.

Photoprotection

Increased melanin may provide some degree of protection against UV radiation.

Important Considerations:

Not FDA Approved: Melanotan 2 is not approved for human or veterinary use in most countries.

Side Effects: Reported side effects include nausea, flushing, darkening of moles, increased blood pressure, and spontaneous erections

Tesamorelin, CJC-1295, and Ipamorelin are advanced peptides that support natural growth hormone production, promoting recovery, fat loss, and overall vitality.

PT 141 works by stimulating melanocortin receptors in the brain. It can be injected under the skin or inhaled through the nose as a treatment for sexual dysfunction. It is known for taking effect quickly, usually in less than one hour.

Sermorelin is a synthetic (man-made) version of a naturally occurring substance that causes release of growth hormone from the pituitary gland. Growth hormone is naturally produced by the pituitary gland and is necessary for growth in children

Methycobal Injection should be used exactly as prescribed by the doctor. Follow all directions on the prescription label and read all medication guides before use. You should use it regularly and at a fixed time each day to get the most benefit from it. This medicine may be only part of a complete program of treatment that also includes making changes to your diet and taking other medicines and supplements. Learn about the foods you should eat to make sure you get enough vitamin B12 in your diet.

Methycobal Injection is generally safe and does not usually cause any common side effects. Some medicines can decrease the absorption of vitamin B12, let your doctor know all other medicines you are taking to make sure you are safe. To make sure it is safe for you, before using the medicine let your doctor also know if you have any medical conditions such as Leber's disease, liver disease, or kidney disorder.